Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
DFLI 
Chardan NexTech Acquisition 2 Corp (DFLI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: DFLI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $1
1 Year Target Price $1
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.86% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 131.66M USD | Price to earnings Ratio - | 1Y Target Price 1 |
Price to earnings Ratio - | 1Y Target Price 1 | ||
Volume (30-day avg) 2 | Beta -0.21 | 52 Weeks Range 0.15 - 4.98 | Updated Date 11/6/2025 |
52 Weeks Range 0.15 - 4.98 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.76 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -55.84% | Operating Margin (TTM) -20.19% |
Management Effectiveness
Return on Assets (TTM) -17.84% | Return on Equity (TTM) -1460.48% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 127177912 | Price to Sales(TTM) 2.41 |
Enterprise Value 127177912 | Price to Sales(TTM) 2.41 | ||
Enterprise Value to Revenue 2.33 | Enterprise Value to EBITDA 48.26 | Shares Outstanding 120786915 | Shares Floating 59908655 |
Shares Outstanding 120786915 | Shares Floating 59908655 | ||
Percent Insiders 1.49 | Percent Institutions 4.04 |
Upturn AI SWOT
Chardan NexTech Acquisition 2 Corp
Company Overview
History and Background
Chardan NexTech Acquisition 2 Corp. (Nasdaq: CNTQ) was a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It has completed its merger with Immunome (IMNM)
Core Business Areas
- Special Purpose Acquisition Company: CNTQ was a SPAC, which focuses on identifying and merging with a private company to take it public. The focus of this spac was initially identifying a target in a technology company
Leadership and Structure
As a SPAC, CNTQ was led by a management team focused on deal sourcing and execution. After merger with Immunome, the new leadership team reflected Immunome's management.
Top Products and Market Share
Key Offerings
- SPAC Structure: CNTQ's primary offering was its publicly listed SPAC structure which it would use to attract and merge with a company. Competitors are other SPACs.
Market Dynamics
Industry Overview
The SPAC market is a segment of the IPO market. It experiences fluctuations based on investor sentiment, regulatory changes, and overall economic conditions.
Positioning
CNTQ positioned itself as a SPAC focused on the next generation of technology companies.
Total Addressable Market (TAM)
The TAM for the SPAC market fluctuates significantly. CNTQ's positioning targeted a subset of this market - technology companies, which has a TAM in the trillions. CNTQ was positioned to capture a small fraction of this through its initial public offering and subsequent merger.
Upturn SWOT Analysis
Strengths
- Experienced Management Team
- Access to Public Capital
- Flexibility in Deal Structure
Weaknesses
- Dependence on Identifying a Suitable Target
- Dilution to Existing Shareholders
- Time Sensitivity
Opportunities
- Increasing Interest in SPAC Transactions
- Attractiveness to Private Companies Seeking Public Listing
- Favorable Regulatory Environment
Threats
- Increased Competition from Other SPACs
- Unfavorable Market Conditions
- Regulatory Changes
Competitors and Market Share
Key Competitors
- DNAB
- SV
- EQD
Competitive Landscape
The competitive landscape is intensely competitive with numerous SPACs seeking targets. The key differentiator is the management team's expertise and deal-sourcing capabilities. The listed companies are just examples of a highly competitive market.
Major Acquisitions
Immunome
- Year: 2022
- Acquisition Price (USD millions): 226
- Strategic Rationale: Took Immunome public, providing it with capital for research and development of antibody-based therapeutics.
Growth Trajectory and Initiatives
Historical Growth: Growth is dependent on the performance of the merged company after the acquisition.
Future Projections: Future growth is tied to Immunome's pipeline and market penetration.
Recent Initiatives: Recent initiatives involve advancing Immunome's drug development programs.
Summary
Chardan NexTech Acquisition 2 Corp. was a SPAC aimed at merging with a private technology company, and it successfully merged with Immunome. The company had access to capital through its IPO and aimed to capitalize on the growing interest in SPAC transactions. CNTQ faced threats from competition from other SPACs and market volatility. The company's financial performance and growth trajectory depend on the success of Immunome's business operations.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Press Releases
- Financial News Outlets
Disclaimers:
This analysis is based on available information and is not financial advice. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Chardan NexTech Acquisition 2 Corp
Exchange NASDAQ | Headquaters Reno, NV, United States | ||
IPO Launch date 2022-10-07 | Founder, Chairman of the Board, President, CEO & Interim CFO Dr. Denis Phares | ||
Sector Industrials | Industry Electrical Equipment & Parts | Full time employees 139 | Website https://dragonflyenergy.com |
Full time employees 139 | Website https://dragonflyenergy.com | ||
Dragonfly Energy Holdings Corp. engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and industrial and energy storage markets. It operates in two segments, direct-to-consumers and original equipment manufacturers. The company provides lithium power systems comprising solar panels, chargers and inverters, system monitoring, alternator regulators, accessories, and others. It also offers battery management systems for monitoring and controlling of battery systems, and to protect battery cells from damage in various scenarios. The company provides its products under the Dragonfly Energy, Battle Born, and Wakespeed brand names. Dragonfly Energy Holdings Corp. is headquartered in Reno, Nevada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.